Yuki Noguchi
Yuki Noguchi is a correspondent on the Science Desk based out of NPR's headquarters in Washington, D.C. She started covering consumer health in the midst of the pandemic, reporting on everything from vaccination and racial inequities in access to health, to cancer care, obesity and mental health.
Since joining NPR in 2008, Noguchi has also covered a range of business and economic news, with a special focus on the workplace — anything that affects how and why we work. In recent years, she has covered the rise of the contract workforce, the #MeToo movement, the Great Recession and the subprime housing crisis. In 2011, she covered the earthquake and tsunami in her parents' native Japan. Her coverage of the impact of opioids on workers and their families won a 2019 Gracie Award and received First Place and Best In Show in the radio category from the National Headliner Awards. She also loves featuring offbeat topics, and has eaten insects in service of journalism.
Noguchi started her career as a reporter, then an editor, for The Washington Post.
Noguchi grew up in St. Louis, inflicts her cooking on her two boys and has a degree in history from Yale.
-
Nonprofit RIP Medical Debt buys up unpaid hospital bills plaguing low-income patients and frees them from having to pay. -
JUUL Labs is no longer allowed to sell or distribute its e-cigarette or vaping products in the U.S. The FDA said its review found Juul products potentially harmful. The company plans to fight back.
-
More than one in 20 Americans struggled with serious mental illness even before the pandemic hit, and the shutdown of services and support networks took a toll. But many found ways to get through it. -
Medication accounts for more than half of abortions, fueled in part by a greater reliance on telehealth. How would a Supreme Court decision overturning Roe v. Wade affect abortion pills availability?
-
If the Supreme Court over turns Roe versus Wade, it would trigger abortion bans and restrictions in 26 states. But the ruling will most impact poor people and communities of color.
-
The state's program of free cancer screening and treatment is reducing inequities. Key to its success is robust outreach by patient navigators who connect with those least likely to seek care. -
For some people, getting a positive coronavirus test could mean loss of income or other life disruptions. Doctors worry about growing disincentives to test and how this could prolong the pandemic. -
Rapid tests for COVID-19 are proving difficult to find both for local governments and individuals. The Biden administration says relief is on the way. But what's behind the supply challenges?
-
A ban on using telemedicine to prescribe controlled medications was suspended in the pandemic. That's allowed many to seek opioid addiction treatment, but some worry about potential for abuse. -
The run on at-home COVID tests highlights some of the country's desperation in getting critical testing capacity up to speed. There are potentially some other roadblocks with other forms of testing.
